Ligandrol

DB13934InvestigationalSmall molecule

Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis.

Chemical structure of Ligandrol
Mechanism
Curator reviewed
Formula / weight
C14H12F6N2O · 338.253 g/mol (avg)
Code names
LGD-4033 · VK-5211

Resolves to

Compound
UNII1EJT54415ACAS1165910-22-4
Structure
InChIKeyOPSIVAKKLQRWKC-VXGBXAGGSA-NSMILESO[C@H]([C@H]1CCCN1C1=CC=C(C#N)C(=C1)C(F)(F)F)C(F)(F)F
Targets
P10275AR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ligandrol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In